| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | birinapant | CTRPv2 | pan-cancer | AAC | -0.072 | 0.07 |
| mRNA | avrainvillamide | CTRPv2 | pan-cancer | AAC | 0.077 | 0.07 |
| mRNA | BRD-K26531177 | CTRPv2 | pan-cancer | AAC | 0.07 | 0.07 |
| mRNA | GSK461364 | CTRPv2 | pan-cancer | AAC | 0.06 | 0.07 |
| mRNA | KU-60019 | CTRPv2 | pan-cancer | AAC | -0.066 | 0.07 |
| mRNA | navitoclax:piperlongumine (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.067 | 0.07 |
| mRNA | GMX-1778 | CTRPv2 | pan-cancer | AAC | 0.067 | 0.07 |
| mRNA | Gemcitabine | CTRPv2 | pan-cancer | AAC | 0.062 | 0.07 |
| mRNA | SB-225002 | CTRPv2 | pan-cancer | AAC | 0.057 | 0.07 |
| mRNA | BMS-270394 | CTRPv2 | pan-cancer | AAC | 0.068 | 0.08 |